0001062993-23-016717.txt : 20230817
0001062993-23-016717.hdr.sgml : 20230817
20230817162419
ACCESSION NUMBER: 0001062993-23-016717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230815
FILED AS OF DATE: 20230817
DATE AS OF CHANGE: 20230817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hippel James
CENTRAL INDEX KEY: 0001603594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231182245
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-15
0000842023
BIO-TECHNE Corp
TECH
0001603594
Hippel James
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
CFO
0
Common Stock
57561
D
Stock Options (Right to Buy)
31.26
2024-08-09
Common Stock
189156
189156
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
72264
72264
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
96356
96356
D
Stock Options (Right to Buy)
47.60
2026-08-07
Common Stock
79744
79744
D
Stock Options (Right to Buy)
47.60
2026-08-07
Common Stock
106324
106324
D
Stock Options (Right to Buy)
66.97
2027-08-05
Common Stock
57440
57440
D
Stock Options (Right to Buy)
66.97
2027-08-05
Common Stock
33300
33300
D
Restricted Stock Units
Common Stock
12876
0
D
Stock Options (Right to Buy)
66.97
2027-08-05
Common Stock
76588
76588
D
Restricted Stock Units
Common Stock
7780
7780
D
Stock Options (Right to Buy)
120.46
2028-08-06
Common Stock
30400
30400
D
Stock Options (Right to Buy)
120.46
2028-08-06
Common Stock
40536
40536
D
Restricted Stock Units
Common Stock
10912
10912
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
33916
33916
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
45220
45220
D
Restricted Stock Units
2023-08-15
4
A
0
12798
0
A
Common Stock
12798
12798
D
Stock Options (Right to Buy)
84.61
2023-08-15
4
A
0
34442
0
A
2030-08-15
Common Stock
34442
34442
D
Stock Options (Right to Buy)
84.61
2023-08-15
4
A
0
45923
0
A
2030-08-15
Common Stock
45923
45923
D
Fully exercisable.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
On 8/5/2023, the Board of Directors certified vesting of 12,876 performance RSUs.
Options to purchase 57,440 shares are vested. Options to purchase 19,148 shares vest on 8/5/2024.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 20,268 shares are vested. Options to purchase 10,136 shares vest on 8/6/2024 and options to purchase 10,134 shares vest on 8/6/2025.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 11,304 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026 and options to purchase 11,308 shares vest on 8/15/2024.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/27, and options to purchase 11,480 shares vest on 8/15/2026.
/s/ Andrew Nick, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
2023-08-17